Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

CardioKinetix, Parachute device, Heart Failure device therapy
Feature | Heart Failure | Abha Mishra

New cardiovascular device therapies for atrial fibrillation (AF) and heart failure (HF) are rapidly evolving with the ...

Home September 29, 2016
Home
News | EP Lab

September 27, 2016 — In August, the European Heart Rhythm Association (EHRA) and EP Europace journal announced the ...

Home September 27, 2016
Home
News | Antiplatelet and Anticoagulation Therapies

September 1, 2016 — First outcome results from the GLORIA-AF Registry show that treatment with Pradaxa (dabigatran ...

Home September 01, 2016
Home
News | Cardiac Resynchronization Therapy Devices (CRT)

August 30, 2016 — Medtronic plc announced results from the Cardiac Resynchronization Therapy Efficacy Enhancement (CRTee ...

Home August 30, 2016
Home
Cybersecurity concerns were raised over the St. Jude Medical (SJM) Merlin@home EP device home monitoring system
Feature | EP Lab | Dave Fornell

August 29, 2016 — Investment research firm Muddy Waters Capital released a report Aug. 25 saying it believes St. Jude ...

Home August 29, 2016
Home
News | Antiplatelet and Anticoagulation Therapies

August 16, 2016 — Warfarin prescribed to prevent strokes in atrial fibrillation may not adequately control blood ...

Home August 16, 2016
Home
Technology

August 15, 2016 — The U.S. Food and Drug Administration has granted market approval for the Biosense Webster Thermocool ...

Home August 15, 2016
Home
Technology | Implantable Cardioverter Defibrillator (ICD)

August 9, 2016 — The U.S. Food and Drug Administration (FDA) granted market approval for the Emblem MRI Subcutaneous ...

Home August 09, 2016
Home
Watchman, left atrial appendage closure, LAA occluder
Feature | Left Atrial Appendage (LAA) Occluders | Dave Fornell

Patients with atrial fibrillation (AF or Afib) are high risk for stroke due to the formation of thrombus emboli in the ...

Home August 01, 2016
Home
News | Blood Testing

July 12, 2016 — Following a collaborative process with the U.S. Food and Drug Administration (FDA), Alere Inc. will be ...

Home July 12, 2016
Home
pros and cons of new anticoagulation therapies, anticoagulants, dabigatran, Pradaxa, novel oral anticoagulants, NOACs, rivaroxaban, Xarelto, apixaban, Eliquis
Feature | Antiplatelet and Anticoagulation Therapies | Heidi Olson, Pharm.D

With the recent introduction of several novel oral anticoagulants (NOACs) on the U.S. market that have been billed by ...

Home July 26, 2016
Home
News | EP Mapping and Imaging Systems

July 7, 2016 — Abbott recently announced positive results from three clinical studies investigating the benefits ...

Home July 07, 2016
Home
News | Left Atrial Appendage (LAA) Occluders

July 7, 2016 — AtriCure Inc. announced the first patient has been enrolled in the FROST study at William Beaumont ...

Home July 07, 2016
Home
News | Left Atrial Appendage (LAA) Occluders

July 5, 2016 — AtriCure Inc. announced that it has received CE Mark for the AtriClip PRO2 Left Atrial Appendage (LAA) ...

Home July 05, 2016
Home
News | Cardiovascular Clinical Studies

June 28, 2016 — New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom ...

Home June 28, 2016
Home
Subscribe Now